EAN News

Our pick of COVID-19-related cross-sectional case control studies from the scientific press for January 2023.

The 13th EAN Regional Teaching Course took place in Douala, Cameroon on 20 October, a day prior to the 3rd AFAN (African Academy of Neurology) Congress.

The Congress Spin-Off with Masterclasses is a new EAN event that will gather smaller groups of participants, taking outstanding lectures from the previous EAN Annual Congress as a starting point for discussion in a number of masterclasses.

Under the auspices of the Czech Presidency of the Council of the European Union and with support from MEP Ondřej Knotek, The European Academy of Neurology (EAN) gathered a range of stakeholders at the European Parliament in Brussels on Thursday, December 8 to give them a glimpse of EAN’s forthcoming research agenda.

Our paper of the month reports the results of the ENCHANTED 2/MT trial, performed in 44 Chinese hospitals to compare more intensive with less intensive blood pressure management after successful endovascular thrombectomy.

Our authors of the month compared the occurrence of stroke, utilisation of recanalisation procedures, and demographic parameters during the pandemic period with data from the preceding year.

This recent EAN-funded study investigates the prevalence of burnout profiles and their contributing factors in European neurology residents, junior neurologists, and research fellows.

Our highlighted selection of COVID-19-related meta-analyses and systemic reviews from the scientific press for December 2022.

Our pick of COVID-19-related cross-sectional case control studies from the scientific press for December 2022.

EAN President, Paul Boon, reflects on a busy and successful 2022 and wishes all EAN members and friends a joyful holiday season.

Researchers involved in pain science: fill out this survey to have your say on the priorities to be established within the EFIC Pain Research Strategy.

Abstract submission for our next annual congress is now open! EAN Programme Committee Chair, Prof. Ulf Kallweit shares the details on this and other latest news about EAN 2023.

Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months.

Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people.

A new publication in the European Journal of Neurology describes the process of developing and launching the EAN guideline prioritisation procedure.